{"id":144419,"date":"2025-02-05T16:54:48","date_gmt":"2025-02-05T11:24:48","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=144419"},"modified":"2025-02-05T17:17:53","modified_gmt":"2025-02-05T11:47:53","slug":"pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/","title":{"rendered":"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3916254378\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1085774794\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price Movement<\/strong><\/h2><p>The shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/CAPLIPOINT\" target=\"_blank\" rel=\"noreferrer noopener\">Caplin Point Lab Ltd<\/a>, <\/strong>with a market capitalization of Rs 16,722 Crores, closed at Rs 2,199 per share 4.4% higher than its previous close of Rs 2,107. The shares generated a return of 57% in 1 year, 172% in 3 years, and an impressive 703% in 5 years respectively.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened<\/strong><\/h2><p>As per a press release dated February 5,2025, the U.S. Food and Drug Administration has granted its final approval to the subsidiary company of Caplin Point Lab Ltd called Caplin Steriles Ltd.&nbsp;<\/p><p>Caplin Steriles Ltd got its approval from the USFDA for its Abbreviated New Drug Application (ANDA) Procainamide Hydrochloride Injection USP, 1g\/10mL and 1g\/2mL Vials, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) PRONESTYL, from Apothecon Inc.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-302942503\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Procainamide hydrochloride Injection is an antiarrhythmic medicine used to treat certain arrhythmia i.e. abnormal heart rhythm. It restores normal heart rhythm by blocking abnormal electrical signals in the heart.&nbsp;<\/p><p>According to IQVIA (IMS Health), Procainamide hydrochloride Injection had US sales of approximately $20 million for the 12-month period ending December 2024.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Updates<\/strong><\/h2><p>As per a press release dated January 17, 2025, Caplin Steriles Limited has been granted final approval from USFDA for its Levetiracetam in Sodium Chloride Injection, 500mg\/100mL, 1000mg\/100mL and 1500mg\/100mL infusion bags, a generic therapeutic equivalent version of the Reference Listed Drug, from HQ Speciality Pharma Corp.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials<\/strong><\/h2><p>The company reported an increase of 18% in Revenue from Operations from Rs 410 Crores in Q2FY24 to Rs 483 Crores in Q2FY25. Its Net Profits grew by 13% from Rs 116 Crores to Rs 131 Crores during the same period.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>India Pharma Industry<\/strong><\/h2><p>The Indian Pharmaceutical industry is presently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of 9.43% since the past nine years. India has the highest number of pharmaceutical manufacturing facilities that comply with the USFDA and has 500 API producers that make for around 8% of the worldwide API market.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About Caplin Steriles Ltd<\/strong><\/h2><p>Caplin Steriles Limited is a sterile product manufacturing company that is approved by several regulatory agencies such as US FDA, EU-GMP, ANVISA and INVIMA. It has developed and filed 46 ANDAs in the USA on its own and with partners, with 33 approvals so far.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-584432489\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About Caplin Point Lab Ltd<\/strong><\/h2><p>The company was established in 1990 to manufacture a range of ointments, creams and other external applications. Its main research and development facilities are located in Tamil Nadu and has a manufacturing plant in Puducherry, India. It has over 4000 product licenses across the globe with over 650+ pharmaceutical formulations &amp; over 36 therapeutic sections.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By Adhvaitha Nayani<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-3843872281\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.&nbsp; Share Price Movement The shares of Caplin Point Lab Ltd, with a market capitalization of Rs 16,722 Crores, closed at Rs 2,199 per share 4.4% higher than [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31,13525],"tags":[],"class_list":["post-144419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news","category-stock-updates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection\" \/>\n<meta property=\"og:description\" content=\"The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T11:24:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T11:47:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/\",\"name\":\"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2025-02-05T11:24:48+00:00\",\"dateModified\":\"2025-02-05T11:47:53+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection - Trade Brains Features","description":"The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection","og_description":"The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-02-05T11:24:48+00:00","article_modified_time":"2025-02-05T11:47:53+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/","name":"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2025-02-05T11:24:48+00:00","dateModified":"2025-02-05T11:47:53+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-after-its-subsidiary-secured-usfda-approval-for-abnormal-heart-rhythm-injection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 6% after its subsidiary secured USFDA approval for abnormal heart rhythm injection"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=144419"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144419\/revisions"}],"predecessor-version":[{"id":144420,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144419\/revisions\/144420"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=144419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=144419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=144419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}